These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1951002)

  • 1. Comparative hemodynamic effects of mexiletine and quinidine in patients with severe left ventricular dysfunction.
    Gottlieb SS; Weinberg M
    Am Heart J; 1991 Nov; 122(5):1368-74. PubMed ID: 1951002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction.
    Gottlieb SS; Weinberg M
    Eur Heart J; 1992 Jan; 13(1):22-7. PubMed ID: 1577027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and neurohormonal effects of quinidine in patients with severe left ventricular dysfunction secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
    Gottlieb SS; Weinberg M
    Am J Cardiol; 1991 Apr; 67(8):728-31. PubMed ID: 1672482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effect of oral mexiletine administration on left ventricular contractility in patients with congestive heart failure: a study based on mitral regurgitant flow velocity measured by continuous-wave Doppler echocardiography.
    Morita H; Hirabayashi K; Nozaki S; Ohmori K; Yoshikawa K; Matsuo H
    J Clin Pharmacol; 1995 May; 35(5):478-83. PubMed ID: 7657847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
    Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
    Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shellock FG; Shah PK; Berman DS; Rubin SA; Singh BN; Swan HJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):436-40. PubMed ID: 7408403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
    Packer M; Medina N; Yushak M; Lee WH
    Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
    Lefkowitz CA; Moe GW; Armstrong PW
    Am J Cardiol; 1987 Jan; 59(3):59B-63B. PubMed ID: 3101477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
    Duff HJ; Cannon NJ; Sheldon RS
    Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of intravenously administered quinidine on the transplanted human heart.
    Mason JW; Winkle RA; Ingels NB; Daughters GT; Harrison DC; Stinson EB
    Am J Cardiol; 1977 Jul; 40(1):99-104. PubMed ID: 327786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shah PK; Shellock FG; Berman DS; Rubin SA; Singh BN; Swan HJ
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2447-50. PubMed ID: 7422534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of quinidine and famotidine in patients with congestive heart failure.
    Kirch W; Halabi A; Hinrichsen H
    Clin Pharmacol Ther; 1992 Mar; 51(3):325-33. PubMed ID: 1544289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.